BNXT — BioNxt Solutions Balance Sheet
0.000.00%
- CA$31.23m
- CA$36.26m
- CA$0.37m
Annual balance sheet for BioNxt Solutions, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.295 | 2.58 | 1.35 | 0.136 | 0.364 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.293 | 0.306 | 0.546 | 0.459 | 0.283 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.714 | 3.03 | 2.7 | 0.691 | 0.719 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.92 | 5.24 | 1.13 | 0.921 | 0.549 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 8.66 | 8.28 | 9.73 | 1.61 | 1.27 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.38 | 1.47 | 5.45 | 2.02 | 6.55 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 2.33 | 4.28 | 8.06 | 5.74 | 6.55 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 6.32 | 4.01 | 1.67 | -4.13 | -5.28 |
Total Liabilities & Shareholders' Equity | 8.66 | 8.28 | 9.73 | 1.61 | 1.27 |
Total Common Shares Outstanding |